My ePortfolio Register   

The economics of personalised medicine in low and middle income countries

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.12.17
Views: 408

Prof Sue Horton - University of Waterloo, Waterloo, Canada

Sue Horton speaks to ecancer at EAPM 2017 in Belfast.

She spoke from an economic perspective about the affordability of personalised medicine for low and middle income countries. 

A global alliance is needed to make medicines available for low and middle income countries at affordable prices.

One of the main problems is a lack of data surrounding the economics of diagnostics for these countries.  

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence